William Blair & Company’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $25.6K | Hold |
400
| – | – | ﹤0.01% | 1660 |
|
2025
Q1 | $25.4K | Hold |
400
| – | – | ﹤0.01% | 1645 |
|
2024
Q4 | $26.6K | Hold |
400
| – | – | ﹤0.01% | 1670 |
|
2024
Q3 | $27.9K | Hold |
400
| – | – | ﹤0.01% | 1683 |
|
2024
Q2 | $25.9K | Hold |
400
| – | – | ﹤0.01% | 1667 |
|
2024
Q1 | $25.9K | Hold |
400
| – | – | ﹤0.01% | 1659 |
|
2023
Q4 | $26.3K | Hold |
400
| – | – | ﹤0.01% | 1648 |
|
2023
Q3 | $22.8K | Hold |
400
| – | – | ﹤0.01% | 1672 |
|
2023
Q2 | $24.5K | Hold |
400
| – | – | ﹤0.01% | 1676 |
|
2023
Q1 | $25.1K | Hold |
400
| – | – | ﹤0.01% | 1666 |
|
2022
Q4 | $25.4K | Hold |
400
| – | – | ﹤0.01% | 1657 |
|
2022
Q3 | $24K | Hold |
400
| – | – | ﹤0.01% | 1681 |
|
2022
Q2 | $23K | Hold |
400
| – | – | ﹤0.01% | 1712 |
|
2022
Q1 | $25K | Hold |
400
| – | – | ﹤0.01% | 1774 |
|
2021
Q4 | $28K | Hold |
400
| – | – | ﹤0.01% | 1825 |
|
2021
Q3 | $30K | Hold |
400
| – | – | ﹤0.01% | 1737 |
|
2021
Q2 | $31K | Hold |
400
| – | – | ﹤0.01% | 1744 |
|
2021
Q1 | $30K | Hold |
400
| – | – | ﹤0.01% | 1719 |
|
2020
Q4 | $28K | Hold |
400
| – | – | ﹤0.01% | 1676 |
|
2020
Q3 | $23K | Hold |
400
| – | – | ﹤0.01% | 1571 |
|
2020
Q2 | $23K | Hold |
400
| – | – | ﹤0.01% | 1525 |
|
2020
Q1 | $19K | Hold |
400
| – | – | ﹤0.01% | 1499 |
|
2019
Q4 | $22K | Hold |
400
| – | – | ﹤0.01% | 1574 |
|
2019
Q3 | $19K | Hold |
400
| – | – | ﹤0.01% | 1552 |
|
2019
Q2 | $21K | Hold |
400
| – | – | ﹤0.01% | 1580 |
|
2019
Q1 | $22K | Hold |
400
| – | – | ﹤0.01% | 1552 |
|
2018
Q4 | $19K | Hold |
400
| – | – | ﹤0.01% | 1493 |
|
2018
Q3 | $24K | Hold |
400
| – | – | ﹤0.01% | 1505 |
|
2018
Q2 | $22K | Hold |
400
| – | – | ﹤0.01% | 1479 |
|
2018
Q1 | $20K | Buy |
+400
| New | +$20K | ﹤0.01% | 1412 |
|